RUBIUS THERAPEUTICS INC

CUSIP: 78116T103 Class: COM

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 20,990 Value ($000) $4 Avg Close — Range —
Q3 2022
Shares 20,990 Value ($000) $9 Avg Close — Range —
Q2 2022
Shares 20,990 Value ($000) $18 Avg Close — Range —
Q1 2022
Shares 147,257 Value ($000) $811 Avg Close — Range —
Q4 2021
Shares 148,260 Value ($000) $1,435 Avg Close — Range —
Q3 2021
Shares 190,609 Value ($000) $3,408 Avg Close — Range —
Q2 2021
Shares 211,601 Value ($000) $5,165 Avg Close — Range —
Q1 2021
Shares 192,893 Value ($000) $5,112 Avg Close — Range —
Q4 2020
Shares 157,810 Value ($000) $1,198 Avg Close — Range —
Q3 2020
Shares 150,876 Value ($000) $755 Avg Close — Range —
Q2 2020
Shares 151,224 Value ($000) $904 Avg Close — Range —
Q1 2020
Shares 131,171 Value ($000) $583 Avg Close — Range —
Q4 2019
Shares 139,785 Value ($000) $1,328 Avg Close — Range —
Q3 2019
Shares 125,255 Value ($000) $984 Avg Close — Range —
Q2 2019
Shares 121,496 Value ($000) $1,911 Avg Close — Range —
Q1 2019
Shares 88,404 Value ($000) $1,600 Avg Close — Range —
Q4 2018
Shares 37,825 Value ($000) $609 Avg Close — Range —
Q3 2018
Shares 29,468 Value ($000) $707 Avg Close — Range —